Evogene (EVGN) Reports Q1 Loss of $0.24

Go back to Evogene (EVGN) Reports Q1 Loss of $0.24

Evogene Reports First Quarter 2020 Financial Results

May 26, 2020 7:00 AM EDT

REHOVOT, Israel, May 26, 2020 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading computational biology company targeting to revolutionize life-science product development across several market segments, announced today its financial results for the first quarter, ended March 31, 2020.

 

 

Ofer Haviv, Evogene's... More